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ABSTHACT 
The descriptive and anal~t1c epidemmlog;. o( breal:'t cancer is re\·Ie wed. A strong new 
mdicator. age at firl:'t birth. has emerged. Lactation is not protective aga ins t brea,t cancer. 
but multiparity i~ associated with lnw breast cancer risk in a noncausal way. The major 
causal hypotheses are discul:'.c;ed. The fir~t. genetic. is ha!-.ed on the familial aggregation 
of breast cancer. but there is no recognizable patlern of inheritance. The viral hypothesis 
remain~ unevalua1ed. ThP endocrine hvpotheses. relating to progesterone. prolactin. 
androgens. and estrogen~. are reviewed in detail. 
Epidemiologic a11ack upon a diseal:'e proeeeds 111 
two major stages. The first. "descripti\·e epidemi-
ology," desnibcs a disrase in tl:'nns ol the people. 
places, and I line" it arrec·ts. The disNlSl' is de-
scri bed by the answer,. to such qul:'sllon~> as. '"\\'ho 
gets ill'l ····Where rio the~ get iJJ'l ··and "Ha~ the 
frequency of some other charactl:'rist ic of the dis-
ease chan(!ed over t inw''" \\'hen such que,.tionl:i 
are reas(lnably well ammered. the second epidemi-
ologic stage. analytic eptc!emwlogy. hegins. At 1 h1s 
s t age. the truly important question. " \\'h~ c!oesan 
illness occur'? .. ts posed. Anulyltl epidemiology 
formulates causal hypotheses based on a\·ailable 
descripttve mformat 10n and evaluates !>Uch hy-
potheses, usually h~ nonexperimental methods. 
The epideminlog~ of nHlmmarv cancer IS well 
into the anah·ttc !<tage. The destripth·e epidemi-
ology has been elucidated about as well a~ that of 
nearlv any maJor disea!'e. True. our understanding 
ol the descnptlve features b st ill increa!<ing. but 
the goal of the epidemiolo[!ic ;.tudies of mammary 
cancer done today must he analytic. Befnre re,·iew-
ing the hypmheses nm' in ,·ogue. let u~ re\iew 
some of the nHIJnr desrriptiH• features of mum-
mar\' t'ancer. since therE' hll\e bet•n important 
changes within the past three years. 
The major descripll\'C features are 1!1\'en 111 
Table I. Most are well known and I will rcvww here 
on!)- those related to chlidbeanng. for it is these 
concepts which arc ch.1uging. An extensive review 
of both the dc:-.rriptive and the anal\tic epidemi-
olo(!Y of mammary t·am·er has rc•n•nt ly been pre-
sented elsewhere Ill. 
We will deal first with the questHtn nf lactutinn. 
The theory that the risk ol breast t'ance r is lowered 
by nursing acquired some scietHific nediblltty with 
the work of Lane-Ciavpon 111 the IH:.10s I~J. On the 
basis of this rather weak "substanttatwn." lacta -
tion became wideh accepted Oti protcctt\e against 
breast canc·er. Th1s i!' understandable stnt·e, if tt 
were so, lactation would explain much of the 
descriptive epideml()logv of the disease It could 
Th1s swd~ wa~-o supported by 11 FaC'ult~ Re~earC'h 
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ex plam the low rates in the Orient. where lactation 
is frequent a nd prolonged; it could ex pl ain the low 
nsk among women of high parity a nd low social 
class since both of these characteristic, are posi-
tively correlated with lactation . ln addition. it has 
a certa in amou nt of biologic credibility predicated 
on t he premise that a breast which has lactated is 
different from one that has not. Thi!i i,. tantamou nt 
to saymg that until lactation a breast remain::. an 
essent ia lly juvenile organ. Hy the 1940,, twn addi-
tional studies lending support to this theory had 
appeared [:3.4]. In additio n. two studies done in the 
1960s were also positive 15.6]. However. e \·en in 
these posi ti\'e studies. the association has been 
weak. On the other hand , there a re persuasi ,•e 
negattve studtes. f or example. a lar[!e case-control 
s tudy done in seven areas around the world. 
including populations at high. intermediate. and 
low breast cancer risk. failed to find any consistent 
differences bel ween cases and controls with respect 
to several measures of lactation [7]. Other careful 
studies in the United S tates 181. Israel 19]. and 
Lebanon 110] have also been negati\'e. It is now 
generally agreed, at least among epidemiolo[!ists, 
that lactation offers no protec t ion agaimn breas t 
cancer . 
A second descriptive fea ture which has under-
gone revision in recent yea rs i!> the associat ion of 
low breast cancer ri sk with multipari ty, This 
association is valid and repre!>enta ti\'e data illus-
traung It are shown in T able II. Thege data, from 
the international st udy just refe rred to. show the 
usual 50 /0", reduction in risk associated with high 
parity. However. a lthough this association is valid, 
it i,; noncausal. It has been demonstra ted thal the 
association with parity results from the fact that 
both high parity and low breast ca ncer risk a re 
associated wi t h an early age at first b irth (AAF'R l 
Ill]. The data illustrating the association of breasl 
cancer protection with early AAFB a re shown in 
Figure 1. \\'omen who have their fi rst child before 
age 20 have only about one-half the b reast cancer 
risk of women who remain nulliparous. This as-
sociation of low breast c·ancer risk with early AAFB 
fully. or almost fully. explains the relationship of 
low breast cancer risk with high parity: women who 
attai n high pari ty genera lly ha\'e an early AAPB . 
1:1:1 
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TABLE I 
Descripti1.H! Ppidemzo/og\ of mammon· tumors 
C'horocl "'"' i<· 
l.Ra ce 
2. Re ligion 
3. So cioeconomic ~tatu' 
4. Ag e at menarche 
eat fin.t birth 5. Ag 
6. La elation 
7. Pa rit) 
8. An iticial menopause 
eat natural meno-9. Ag 
palll\e 
etght lO.W 
II. Pr 
e 
12. Fa 
eviou~ hrea!>l dis -
ase 
mil) histnl) 
Ri'k I(T<IUp Ri'k 
-
High I.U\\ raun 
Cauca~ian Oriental 5 
,Jewish '? 2 
High Low 2 
Early Late 1.:3 
Late Earlv 3 
None None I 
~ulli- Multi - :l :3 
parous parous 
:\o Ye~ :3 
Law Early 1.5 
Obese Thin 2 
Ye!> :'llo :3 
Positive :'llegative 3 
• Approximate re,ult when risk in high-risk group i~ 
divided by risk in low- ri~k group 
TABLE II 
Estimate.~ nf relatl.l'P ri~k · of brea.~t cancPr. b\ pari(' 11 I j 
-- -
Center 1---
Pant\ 
() I ~ :! > ;) 
Boswn 100 76 81 64 59 5-t 
Glamorgan 100 68 60 6a 61 42 
Athens 100 76 9:l 77 68 58 
Slovenia 100 9:1 89 R.j 83 90 
Sao Paulo 100 78 87 60 62 57 
Taipei HXl i4 48 ·II 47 48 
Tokyo 100 82 84 60 59 :j.j 
--
· Risk relative 1n an arhu raQ ri~k n l 10<1 lor the 
nulltparous 
So. in the last fe~>. years, our understandin!{ of 
breast cancer risk factors has undergone twn main 
changes. The two most strongly en I renched ideas. 
that lacta tion and high parity are associated with 
low breast cancer n sk. have been shown to be 
either wrong or noncausal. Howe\er. a ne\\ and 
s LConger risk indicator, the AAPB, has emerged. 
The effect of this subst itution of risk facturs is 
profound. Obviously an etiologic hypothesis for-
mulated to explain the AAFB phenomenon will be 
very different from one formulated to explain the 
parity phenomenon. Of course. we do not know 
that the association with AAF'H is causal: perhaps 
it is only an index or some more meaningful factor. 
Such a factor, l<lr example. might be the early 
onset of regular ovu lation during adolescence. It 
could then be proposed that ovulation c reates a 
h ormonal milieu ~>.hich ih unfavorable to the initia-
tion of breast cancer . .'mce ovulatory C)cles do 
make a women susceptible to pregnancy. there 
would be protective association between early 
AAFB and breast cancer. 
Another factor that has received some attention 
in the past few yea rs is the age-incidence pattern of 
breast cancer rates in different populations. Exam· 
pies of these a re shown in Figure 2. A detailed 
analysis of the different kinds of age-inc idence 
curves and their implications has been presen ted 
by deWaard [12]. He pointed out that the cont inu-
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ous rising of the rates throughout the life span in 
Western countries. compared with Eastern. is 
quite consistent with the dual etiology of breast 
cancer. ln particular, he has proposed that the 
cause of the disease in the young is related to 
ovarian estrngen producuon whereas that among 
postmenopausal women is more related to adrenal 
estrogens. These are highly credible theories. How-
ever. there is reason to believe i hat even if the 
adrenal i!> invol"ed in the disease among post-
menopausal women, the ovary, too. is likely to be 
involved [13 ]. In any case. we concur with de-
Waard's inlcrpretat ion oft he age-incidence curves. 
that breast cancer has a dual etiology or. at least. 
that there are two periods in a woman's life. 
possibly adole~cence and the menopause. when the 
risk of' breast cancer initiation or promotion is 
relatively high. 
This briel summary represents the major prog-
ress in the descriptive epidemiology of brea:.t 
cancer. With this background. we can now concen-
trate on the major causal hypothese~ being stud-
ied. It is convenient to consider these in three 
major t•ategories: genetic, viral. and endocrine. 
The genetic hypothesis is based nn the undenia-
ble familial aggregation of brea~t cancer. ,Just how 
strong this familial aggregation is remains unclear. 
Anderson [14] has suggested that fpmale relatives 
of premenopausal women with bilateral breast 
cancer have about a 50'·; lifetime chance or de\'el -
opin~ the disease, that is. about 8 times the risk m 
the general population. In addition. several high-
risk families have been idemified in which the 
lifetime probability of de, eloping breast cancer is, 
in fact, about!)()'·, 11:1.161. But it is probably more 
generally true that relatives of hrca!it cancer pa-
tient!' have only 2 :3 time!> tht> general population's 
risk of disease. that is. about a 1:.1 18'·, lifetime 
chance of being affected . 
The genetic hypo! he~i~ suffers from t be fact that 
the di!>Pase is not transmitted in any ret'ognizahle 
pattern of inheritance. Furthermore. several stud-
ies have failed to find differences bNween breast 
cancer case:. and controls with respect to many 
"genetic markers" ll·U7J. Indeed. e,·en the very 
promi!'ing report of wet -type ear cerumen as a 
markt>r of increased breast cancer risk [18] now 
appears to ha,·e bet>n due to a chance association 
[191. The extremely-high-risk families are quite 
rare. and it now seems unlikely that genes account 
for a major pt>rcent of brea::;t cancer. 
At present. the genetic hypothesis is supported 
only by the existence of familial aggregation. 
However. this type of aggregation is equally con-
sistent with an environmental cause since family 
members share many environmental exposures. In 
addition. it is probably true that genes influen('e 
breast cancer. if at all, by their effects on suscepti-
bility and response to virus infe('tion and endocrine 
status. which are themselves major etiologic fac-
tors. 
Viruses have received considerable attention as 
possible causes of human breast cancer ever :.ince 
one was ident i lied as a cause oft he disease in mice. 
Recently this interest has been stimulated by the 
report of greater frt>quency of B-type R:\A virus 
particles. similar to the mouse mammary tumor 
virus, in the milk of women with a family history of 
breast cancer than in women without such a 
history [20 ]. However. more recent data :;uggest 
that only a small proportion oft he particle~ seen in 
human milk are truly indistingui>ohAhle from the 
mouse virus and the proportion of women excreting 
~uch particle!< is similar amon~ those with and 
without a famil) history of breast cancer [21]. 
Some evidence to support the virus hypothesis 
come~ from the nucleic acid hybridization studies 
of Spiegelman and his colleagues [22,:23]. These 
studies ha\·e demonstrated that human brea:,t 
cancer tissue and. apparently. only human breast 
cancer tis~ue contains RNA homnlogou, to the 
RNA genome of the mouse mammary tumor \'irus. 
The few epidemiologic studies aimed at evaluat-
ing the role of a virus in breast can<.:er have been 
negati\e. To place this in perspective, it must be 
acknowledged that epidt>miologit methods de-
signed to iden til~ the role of a viru!> in a disease 
with a long incubation period are very poor. 1t is, 
pPrhap,, of some rele,·ance to the virus hvpothesis 
that in the rat, an intensively studied species 
similar w the mouse. no virus appears to be 
involved in breast <.:anrer. This is especially inter-
esting since the disease tn rat::. is more like that in 
women than is the disease in mice. 
At present. the role of a virul> tn breast cancer 
must be evaluated by laboratory techniques since 
epidemiologic studies are not likel) to be reward-
ing. However. most of the laboratory studie~ could 
be enhanced by the use of epidemiologic informa-
tion in the selection of subject!'. for e\'aluation. The 
weak support for drus involvement in the human 
disease. both from laboratory and population stud-
ies, and the very firm evidence. also from both 
quarters. on the role of hormones. are re!:>ponsible 
for the interest of many im·estigators in the endo-
crine etiology of breast cancer. 
The idea that some aspect of female endo-
crinology is related to breast cancer is natural. 
obvious, and supported by observations that docu-
ment virtually e\·ery aspect of female reproductive 
life in relation to the risk of breast cancer. And yet, 
the hormonal milieu related to breast cancer, 
whether highly conducive to or highly protective 
against breast cancer. is quite compatible with the 
normal appearance and function of women. Thus, 
although hormonal alterations may ultimately be 
known to be blatant in term!'\ of the alterations 
which relate to breast cancer risk, the) are subtle 
in their effect on female maturation and function. 
The four major endocrine hypo! heses relate to 
progesterone, prolactin. androgens, and e!'\trogens. 
Despite the extensive work of the past decade, no 
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progress has been made in shortening the list of 
suspects. On the contrary. the list continue~ to 
lengthen , for only recently has prolactin become a 
major contender and has it been appreciated that 
the several different estrogens shou ld be consid-
ered individually with respect to breast cancer. 
The issues are quite complex. and in this paper 
there is space for only a few summary sta tements 
concerning hormonal relationships to breast can-
cer. 
Our understanding of the role of progesterone in 
breast cancer is quite confused. Some believe that 
it may be ca rcinogenic. others that it may be 
protective. In human subjects, progesterone has 
been correlated both with increased risk of breast 
cancer. as exemplified by the protective effect of 
surgical menopause. and with decreased risk. as 
exemplified by pregnancy. Prolactin is of interest 
in that it almost certainly acts as a breast carcin<,-
gen in animals. However. this may well be through 
its effects on the ovarv. which result in estrogen 
secretion [24). The major argument against Its 
having a role in human subjects 1s that there are 
only two periods in a normal woman·s life. late 
pregnancy and lactation. when she is suhjected to 
increased prolactin secreuon. and neither of t hese 
two periods is associated with increased breast 
cancer risk. 
The androgen metabolite~. especially etio-
cholanolone. are of considerable interest. A long-
term prospective study [251 suggests that the 2-l-hr 
urine excretion of etiocholanolone is a good predic-
tor of breast cancer risk . Women with low levels of 
et iocholanolone were found to be at high risk of 
breast cancer. The report [161 that etiocholanolone 
excretion is essentially similar for Caucasian and 
Oriental women i~ difficult to reconci le with the 
5-fold excess of breast cancer in Caucasian women 
compared with Oriental women. Actually, it is 
difficult to reconcile etiocholanolone with an.) 
causal role in breast cancer since the hormone is 
physiologically inert and has exhibited nenher 
carcinogenic nor anticarcinogenic acti,•ity. Bul-
brook [271 himself has suggested that the impor-
ta nce of etiocholanolone lies more as an indicator 
of an hormonal pattern ot more direct relevance to 
breast cancer risk. or possibly. as the basis for a 
screening te~t. 
A very specific hypothesis about the role of 
estrogens has been reported [181 and mod1fled lu 
accommodate recent epidemiologic findings [191. 
The hypothesis is that the relative amount;; of the 
th ree major estrogen fraction;;-est rone tEl), e:.-
tradiol (E2). and esmol (E:l\-produced bv a 
woman in the decade or so following puberty is a 
determinant of her subsequent breast cancer risk. 
The hypothesis is based on the demonstration of 
d ifferences in carcinogenic potenual among the 
three fractions. Two of the fractions. El and E2. 
have been shown to be carcinogenic but E:~ has not 
although, admittedly, E3 ha,.. not been ,·ery well 
studied. Furthermore. E:3 inhibits the uterine 
growth-promotmg effect of the more active frac-
tions. Although it:. inhthitorv action ha~ not been 
demonstrated for the carcinogenic properties of E 1 
and E2, E3 has been shown to compete with E2 for 
cytoplasmic bindmg s1tes and io inhilllt incorpora-
tion of E2 b~ nuclei of a chem icallv induced rat 
breast tumor 1301. It has also been found that E3 
inhibits the mammarv carrinogenic activity of 
dimethylbenz-anthracene [:311. An age component 
of the hypothesis was added to accommodate the 
epidemiologic findings that suggest that breast 
cancer induction often occurs during the decade or 
so following puberty Thus the estriol ratio lE3/(El 
- E2l ]. which characterizes a woman ·s young 
adulthood. may he a determinant of her ri!;k of 
breast cancer 
The most obvwus test of the hypothesis is to 
compare the estri"l ratios of women who ha\e 
de,·elnped breast cancer w1th those of women who 
have not. Several studies of this type have been 
carried out with inconsi~tent results. All the stud-
ies reported to date can be crttlcized on the basis of 
questionable biochemical methods or haphazard 
selection of cases or c·1mtrols. and all are based on 
small numbers. :Vlanv of the patients have been 
po~tmenopausal and some have had residual tu-
mors. Even if a perfect case-control study of 
urinary estrogen profiles were carried out with 
negative results. this would not be evidence con-
trary to the hypothesis. smce a woman ·s estrogen 
profile at the time she manifests clinical cancer 
may not be the same as that whtch pre,·ailed 
during her adolescence. 
Our approach is to compare the urinary estrogen 
profiles of young women in populations with differ-
ent breast cancer risks , We under!;tand that the 
hypothesis probably cannot be definiteh· estab-
lished on the basis of such population compansons. 
However, to the extent that a l'Orrelation between a 
specillc estrogen profile and breaM cancer risk can 
be demonstrated . the hypothesis would be 
strengthened. Perhaps mure important. w the 
extent that this correlation i~ absent. the h~·pothe­
Sis would be weakened . If consiStent populaunn 
correlations are not found. the hypothesis probably 
should be abandoned. 
Smce the .".-fold difference 111 breast cancer rates 
between A::oian and :--lorth American population,.. is 
one ot the strongest epidemiologic features of the 
disease. the first companson of estrogPn profiles 
was made of women from three areas in Asia with 
Caucasian women from two :\orth American cities. 
The results of this stud' are s trikingly in agree-
ment with predictiom; based on the h\·pothesis 
(:32]. The estnol ratio was considerably hil{her tor 
the As1an than fur the North American women, 
both in specimens collected during the follicular 
phase of the menstrual cycle and 111 those collected 
durin~ the !ureal phase. The diJference was great 
among women aged 15 19 but slight among those 
aged 35 :39 Tht:> main study i5 now nearing com-
pletion. The results to date indicate differences at 
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least a" ~real as theN• nott>d in the pilot stud' 
Thev show a dillrrem·e 10 t'~trwl ratio between 
Asian and Amencnn women :m :~9 vear~ of age. hut 
the difference rs considerabh l<>ss than that among 
women under :ZO. 
I do not kncm ho" man_,. oth(•r opporturulles 
there ure for this t\pe ot populutron compan~on 
nor indeed hm\ mall\ wtll be r~.>qutred lu prm rete a 
convrncing evaluu t ion of t hP hvpm he sis. \\'e hope 
that other group" ol 10vestigator,.. wtll hetoml' 
tnt erE's ted 10 such companson,.., One already re-
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